133 related articles for article (PubMed ID: 36820587)
1. Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.
Wang S; Hu S; Huang S; Su L; Guo Q; Wu B; Ye J; Zhang D; Zhang Y; Zhang W; Wei Y
Medicine (Baltimore); 2023 Feb; 102(6):e32772. PubMed ID: 36820587
[TBL] [Abstract][Full Text] [Related]
2. Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.
Ye J; Hu S; Zhang W; Zhang D; Zhang Y; Yu D; Peng J; Xu J; Wei Y
Front Surg; 2022; 9():893429. PubMed ID: 35769151
[TBL] [Abstract][Full Text] [Related]
3. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
4. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of lung squamous cell carcinoma patients with second primary malignancies: a SEER database study.
Han W; Wang S; Su L; Xu J; Wei Y
Front Oncol; 2024; 14():1294383. PubMed ID: 38444672
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
8. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
Moon SW; Seo JH; Jeon HW; Moon MH
Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
13. Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study.
Rao H; Zhou S; Mei A; Yao A; Xie S
Aging (Albany NY); 2022 Jun; 14(11):4827-4838. PubMed ID: 35680571
[TBL] [Abstract][Full Text] [Related]
14. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
17. Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study.
Zhang R; Cai L; Wang G; Wen Y; Wang F; Zhou N; Zhang X; Huang Z; Yu X; Xi K; Yang L; Zhao D; Lin Y; Zhang L
Front Oncol; 2019; 9():1552. PubMed ID: 32117785
[No Abstract] [Full Text] [Related]
18. The number of lymph nodes examined is associated with survival outcomes and nodal upstaging in patients with stage I small cell lung cancer.
Chen Y; Zhang J; Jiang C; Zhang H; Fan P; Yu H; Zhang H; Fei K; Zhang P
Surg Oncol; 2021 Jun; 37():101513. PubMed ID: 33429326
[TBL] [Abstract][Full Text] [Related]
19. Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III.
Wang H; Zhang J; Shi F; Zhang C; Jiao Q; Zhu H
Oncotarget; 2017 May; 8(21):34923-34934. PubMed ID: 28432275
[TBL] [Abstract][Full Text] [Related]
20. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
Lin L; Wang D; Chen H
PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
